🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

249 results for “ISTA” Clear

  1. Realgar-Indigo Naturalis Formulation Combined with Anlotinib

    First Tracks Biotherapeutics

    Platinum-resistant Ovarian Cancer (PROC)

    approved small molecule active

    1 trial

  2. Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  3. lactulose (Kristalose®)

    CUMBERLAND PHARMACEUTICALS INC

    Constipation

    approved small molecule completed

    1 trial

  4. DAOSiN®/ Placebo & ProvokAmin® Ingestion

    Century Therapeutics

    Histamine Intolerance

    other completed

    1 trial

  5. Fei Re Qing Granules

    First Tracks Biotherapeutics

    Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection

    small molecule active

    1 trial

  6. HCQ/CQ and CAB combined treatment

    China SXT Pharmaceuticals

    Resistance, Disease

    small molecule active

    1 trial

  7. antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)

    China SXT Pharmaceuticals

    Pain

    small molecule completed

    1 trial

  8. carbohydrates

    China SXT Pharmaceuticals

    Insulin Resistance

    other active

    1 trial

  9. treatment with or without colistin

    China SXT Pharmaceuticals

    Carbapenem-Resistant Enterobacteriaceae Infection

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources